---
figid: PMC5140697__nihms827176f2
figlink: /pmc/articles/PMC5140697/figure/F2/
number: F2
caption: 'Insulin receptor (IR) and IGF-1 receptor (IGF-1R) can either homo- or heterodimerize
  to activate their TK domains; this stimulates downstream RAS/RAF/MEK/ERK and RAS/PI3K/AKT/mTOR
  signal transduction pathways, which induce survival, proliferation, angiogenesis
  and ribosomal synthesis of several proteins, including hypoxia-induced factor 1α
  (HIF-1α). PI3K, RAS and HIF-1α promote crucial metabolic modifications in neoplastic
  cells, including glucose uptake and aerobic glycolysis, as well as de novo synthesis
  of fatty acids. Since RAS/RAF/MEK/ERK and RAS/PI3K/AKT/mTOR cascades can also be
  activated by other membrane receptors, including EGFR and HER2, combining inhibition
  of IGF-1/IGF-1R pathway with targeting of other TK receptors or their downstream
  mediators (e.g. mTOR) could synergistically inhibit cancer cell proliferation and
  survival.Abbreviations. EGFR: epidermal growth factor receptor; HER2: human epidermal
  growth factor receptor 2; HIF1-α: hypoxia-induced factor 1-α; IGF-1: insulin-like
  growth factor 1; IGFBPs: IGF-1 binding proteins; IGF-1R: IGF-1 receptor; IR: insulin
  receptor; mTOR: mammalian target of rapamycin; PI3K: phosphoinositide 3-kinase;
  S6K: S6 kinase.'
pmcid: PMC5140697
papertitle: 'Targeting cancer metabolism: dietary and pharmacological interventions.'
reftext: Claudio Vernieri, et al. Cancer Discov. ;6(12):1315-1333.
pmc_ranked_result_index: '8454'
pathway_score: 0.9617072
filename: nihms827176f2.jpg
figtitle: 'Targeting cancer metabolism: dietary and pharmacological interventions'
year: ''
organisms:
- Homo sapiens
ndex: a667dbe6-de9c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5140697__nihms827176f2.html
  '@type': Dataset
  description: 'Insulin receptor (IR) and IGF-1 receptor (IGF-1R) can either homo-
    or heterodimerize to activate their TK domains; this stimulates downstream RAS/RAF/MEK/ERK
    and RAS/PI3K/AKT/mTOR signal transduction pathways, which induce survival, proliferation,
    angiogenesis and ribosomal synthesis of several proteins, including hypoxia-induced
    factor 1α (HIF-1α). PI3K, RAS and HIF-1α promote crucial metabolic modifications
    in neoplastic cells, including glucose uptake and aerobic glycolysis, as well
    as de novo synthesis of fatty acids. Since RAS/RAF/MEK/ERK and RAS/PI3K/AKT/mTOR
    cascades can also be activated by other membrane receptors, including EGFR and
    HER2, combining inhibition of IGF-1/IGF-1R pathway with targeting of other TK
    receptors or their downstream mediators (e.g. mTOR) could synergistically inhibit
    cancer cell proliferation and survival.Abbreviations. EGFR: epidermal growth factor
    receptor; HER2: human epidermal growth factor receptor 2; HIF1-α: hypoxia-induced
    factor 1-α; IGF-1: insulin-like growth factor 1; IGFBPs: IGF-1 binding proteins;
    IGF-1R: IGF-1 receptor; IR: insulin receptor; mTOR: mammalian target of rapamycin;
    PI3K: phosphoinositide 3-kinase; S6K: S6 kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NRAS
  - AKT1
  - MTOR
  - AKT3
  - KRAS
  - MAP2K2
  - ERBB2
  - PIK3R5
  - PIK3R4
  - IGF1
  - PIK3R6
  - MAPK3
  - HIF1A
  - MAPK1
  - EGFR
  - HRAS
  - MAP2K1
  - PIK3CB
  - AKT2
  - PIK3CD
  - PIK3CG
  - BRAF
  - ARAF
  - RAF1
  - IGF1R
  - PIK3R3
  - PIK3CA
  - Temsirolimus
  - arginine
  - Fatty acid
  - Glucose
  - glutamine
  - leucine
  - Metformin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: arginine
  source: MESH
  identifier: D001120
- word: Fatty acid
  source: MESH
  identifier: D005227
- word: Glucose
  source: MESH
  identifier: D005947
- word: glutamine
  source: MESH
  identifier: D005973
- word: leucine
  source: MESH
  identifier: D007930
- word: Metformin
  source: MESH
  identifier: D008687
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5140697__F2
redirect_from: /figures/PMC5140697__F2
figtype: Figure
---
